Crescent Capital BDC offers a compelling 12.6% regular dividend yield and trades at a 31% discount to book value. CCAP maintains a conservatively managed, diversified portfolio with strong dividend coverage and an improving non-accrual rate. The BDC's focus on sponsor-backed companies, solid balance sheet, and potential for increased non-interest income support its investment case.

Ameren raises its 2025 outlook and invests heavily in long-term growth with clean-energy and nuclear expansion plans.

HOUSTON and CAMBRIDGE, Mass., Nov. 19, 2025 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX) (Salarius or the Company) cites an error on the S&P CapIQ platform and reiterates that its common stock continues to trade uninterrupted on the Nasdaq Stock Market under the stock ticker “SLRX.

Carvana Co (NYSE:CVNA) is trading 2.3% higher at $324.67 this afternoon, attempting to extend a rebound off the $280 level, a site that captured its June pullback as well.

SAN DIEGO , Nov. 19, 2025 /PRNewswire/ -- Johnson Fistel, PLLP announces that a class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Avantor, Inc. (NYSE: AVTR) common stock during the period between March 5, 2024 and October 28, 2025, inclusive (the "Class Period"). The lawsuit seeks to recover losses for investors under the federal securities laws.

Novavax, Inc. ( NVAX ) Jefferies London Healthcare Conference 2025 November 19, 2025 11:30 AM EST Company Participants Ruxandra Draghia-Akli - Executive VP and Head of Research & Development James Kelly - Executive VP, CFO & Treasurer Conference Call Participants Jiale Song - Jefferies LLC, Research Division Presentation Jiale Song Jefferies LLC, Research Division Welcome to Jefferies London Healthcare Conference 2025. My name is Roger Song, one of the senior analysts cover semicap biotech in the U.S. It is my pleasure to have my next fireside chat with Novavax.

Star Bulk Carriers Corp. ( SBLK ) Q3 2025 Earnings Call November 19, 2025 11:00 AM EST Company Participants Christos Begleris Nicos Rescos - Chief Operating Officer Charis Plakantonaki - Chief Strategy Officer Constantinos Simantiras - Head of Market Research Hamish Norton - President Petros Pappas - Founder, CEO & Director Conference Call Participants Christopher Robertson - Deutsche Bank AG, Research Division Omar Nokta - Jefferies LLC, Research Division Presentation Operator Thank you for standing by, ladies and gentlemen, and welcome to the Star Bulk Carriers Conference Call on the Third Quarter 2025 Financial Results. We have with us today …

Agios Pharmaceuticals, Inc. ( AGIO ) Discusses Topline Results from RISE UP Phase 3 Trial of Mitapivat in Sickle Cell Disease November 19, 2025 8:00 AM EST Company Participants Morgan Sanford Brian Goff - CEO & Director Sarah Gheuens - Chief Medical Officer and Head of Research & Development Tsveta Milanova - Chief Commercial Officer Conference Call Participants Biree Andemariam Eric Schmidt - Cantor Fitzgerald & Co., Research Division Salveen Richter - Goldman Sachs Group, Inc., Research Division Ellen Horste - TD Cowen, Research Division Alec Stranahan - BofA Securities, Research Division Emily Bodnar - H.C. Wainwright & Co, LLC, …

Tesla CEO Elon Musk says the future of the company hinges on its next-generation microchips — but securing enough of them will be costly.

Investors need to pay close attention to Atlantic Union Bankshares stock based on the movements in the options market lately.

HIVE Digital Technologies' Q2 revenues soar on mining strength and HPC growth, but the stock slips as Bitcoin price swings pressure sentiment.

As anyone starts to wade into retirement, the first financial things on their mind are likely all about how to handle market volatility and inflation.

SAN DIEGO , Nov. 19, 2025 /PRNewswire/ -- Johnson Fistel, PLLP announces that a class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Inspire Medical Systems, Inc. (NYSE: INSP) common stock between August 6, 2024 and August 4, 2025, inclusive (the "Class Period"). The lawsuit seeks to recover losses for investors under the federal securities laws.

BENSALEM, Pa., Nov. 19, 2025 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith continues its investigation on behalf of Zimmer Biomet Holdings, Inc. (“Zimmer” or the “Company”) (NYSE: ZBH) investors concerning the Company's possible violations of federal securities laws.

BENSALEM, Pa., Nov. 19, 2025 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith continues its investigation on behalf of Trex Company, Inc. (“Trex” or the “Company”) (NYSE: TREX) investors concerning the Company's possible violations of federal securities laws.

BENSALEM, Pa., Nov. 19, 2025 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith continues its investigation on behalf of Varonis Systems, Inc. (“Varonis” or the “Company”) (NASDAQ: VRNS) investors concerning the Company's possible violations of federal securities laws.

SAN DIEGO , Nov. 19, 2025 /PRNewswire/ -- Shareholder rights law firm Johnson Fistel, PLLP has launched an investigation into whether the board members of Sealed Air Corporation (NYSE: SEE) breached their fiduciary duties in connection with the proposed sale of the company to CD&R. If you own Sealed Air shares and believe this proposed transaction undervalues your investment, please consider joining our investigation.

Dwight Jacobs to retire after more than two decades of distinguished service CHARLOTTE, N.C. , Nov. 19, 2025 /PRNewswire/ -- Duke Energy today announced that Katie Aittola will become senior vice president, supply chain and real estate, and chief procurement officer, effective Jan. 1.

Atlanta, Nov. 19, 2025 (GLOBE NEWSWIRE) -- Piedmont Realty Trust, Inc. (“Piedmont” or the “Company”) (NYSE: PDM) today announced the pricing of the cash tender offer to purchase any and all of its outstanding 9.250% senior notes due 2028 (the “notes”) for the consideration described below by its operating partnership, Piedmont Operating Partnership, LP (the “Operating Partnership”). The table below sets forth the applicable Reference Yield and Consideration for the notes, as calculated at 2:00 p.m., New York City time, today, November 19, 2025, in accordance with the Offer to Purchase.

Syntec Optics' Q3 results grapple with rising labor and overhead costs, audit fees, and cash constraints. Despite these pressures, the company projects stronger Q4 revenues from key growth sectors.